Abstract: An injection system can have a Syringe Dose and Position Apparatus (SDPA) mounted to a syringe. The SDPA can have one or more circuit boards. The SDPA can include one or more sensors for determining information about an injection procedure, such as the dose measurement, injection location, and the like. The SDPA can also include a power management board, which can be a separate board than a board mounted with the sensors. The syringe can also include a light source in the needle. Light emitted from the light source can be detected by light detectors inside a training apparatus configured to receive the injection. The syringe can have a power source for powering the sensors and the light source. The SDPA and the power source can be mounted to the syringe flange.

Abstract: A single space parking meter assembly for retrofitting onto an existing coin vault assembly includes a number of parking meter components enclosed within a protective outer covering that is rotatably or slidably engageable with the coin vault assembly when a bottom surface of the protective outer covering is positioned against or adjacent to an upper surface of the coin vault assembly. A locking mechanism secures the protective outer covering to the coin vault assembly when the protective outer covering is engaged with the coin vault assembly.

Abstract: A parking meter may have a housing that is formed at least significantly of an impact resistant material. In particular, the impact resistant material may comprise one of a polycarbonate copolymer or polycarbonate blended resin, a nylon-based copolymer, or a nylon-based polymer that includes long glass fiber or Kevlar fiber. The housing encloses the parking meter components to provide protection for the parking meter components against an external environment and vandalism attacks.

Abstract: Provided herein are compositions, systems, and methods for treating a subject with, or elevated risk for, a cardiovascular disease (CVD) involving dysregulated platelet activation comprising: treating the subject with a composition comprising an OR2L13 activating agent (e.g., carvone; 2-tert-Butyl-4-Methylphenol; or 2-tert-Butyl-5-Methylphenol). In certain embodiments, the CVD comprises abdominal aortic aneurysm (AAA) or thrombosis.

Abstract: Systems and methods for generation and use of intellectual-property (IP) landscaping platform architectures are disclosed. A landscaping component may be utilized to produce refined clusters of IP assets using user seeded searches in varying areas of interest, such as, for example, target technical fields, targeted publications, targeted products, and/or competitor entity portfolios. The landscaping component may be further utilized to produce an interactive graphical element including a spatial representation of the clusters of IP assets. The interactive graphical element may include various functionalities and/or information associated with the clusters of IP assets.

Abstract: A parking meter housing may be provided as a first housing secured or fixed at the parking meter location and a second separable housing that can be locked to the first housing. The second housing can have a number of parking meter components mounted to it. The first and second housings have cooperating features that allow the second housing, once it is at least partially separated from the first housing, to be supported by the first housing in a position that facilitates performing maintenance on the parking meter components.

Abstract: The present disclosure relates to ?v?3 and/or ?v?5 integrins antagonist radiopharmaceuticals and their use in a theragnostic approach for selection and therapy of human subjects with tumors overexpressing ?v?3 and/or ?v?5 integrins. In particular, the present disclosure relates to a pharmaceutical composition of ?v 177Lu radiolabeled ?v?3 and/or ?v?5 integrins antagonist, for use in treating tumors overexpressing ?v?3 and/or ?v?5 integrins in a human subject eligible for said treatment, wherein said subject has been selected for the treatment by PET/CT or PET/MRI or SPECT/CT or SPECT/MRI imaging with the same ?v?3 and/or ?v?5 integrins antagonist but with 68-Ga as radiometal for use as imaging agent.

Abstract: Methods that may be used for the manufacture of the chemical compound (R)-Reticuline and synthesis precursors thereof. Compositions useful for the synthesis (R)-Reticuline and synthesis precursors are also provided.

Abstract: A method and apparatus for processing flow specification (Flowspec) messages to one or more of a plurality of customer networks by a controller device coupled to the plurality of customer networks. Preferably a network controller monitors network traffic flowing through each of the customer networks for detecting a network attack in one of the plurality of customer networks, via monitoring of the network traffic. Upon detection of a network attack, a Flowspec message is generated for the customer network detected to be under network attack wherein the Flowspec message is configured specifically for that customer network. The generated Flowspec message is transmitted to the customer network detected to be under network attack for implementation by the customer network for mitigation of the detected network attack.

Abstract: A wireless parking meter with an improved antenna location is described. The antenna may be located within a covering protruding from the top of the parking meter, allowing radio frequency (RF) signals to be transmitted through a portion of the parking meter with high permittivity to the RF signals. Additionally or alternatively, the antenna may be located within the parking meter housing above a lower parking meter mechanism housing so that RF signals can be transmitted through the dome covering of the parking meter, which may have a high permittivity to the RF signals.

Abstract: An injection system can have a Syringe Dose and Position Apparatus (SDPA) mounted to a syringe. The SDPA can have one or more circuit boards. The SDPA can include one or more sensors for determining information about an injection procedure, such as the dose measurement, injection location, and the like. The SDPA can also include a power management board, which can be a separate board than a board mounted with the sensors. The syringe can also include a light source in the needle. Light emitted from the light source can be detected by light detectors inside a training apparatus configured to receive the injection. The syringe can have a power source for powering the sensors and the light source. The SDPA and the power source can be mounted to the syringe flange.

Abstract: The invention is directed to an inhaler device for inhalable liquids, in particular for the administration of inhalable volatile liquids such as halogenated volatile liquids, to a patient. According to particular embodiments, the inhaler device may include a liquid container for hermetically storing inhalable liquid; a wicking material for supporting inhalable liquid; a piercing member configured to pierce the liquid container, wherein the liquid container may be provided in a first position in which the piercing member does not engage the liquid container and inhalable liquid remains hermetically stored within the liquid container, and the liquid container may be displaced from the first position to a second position such that the piercing member pierces the liquid container to release inhalable liquid onto the wicking material, whereby during inhalation inhalable liquid vapor from the wicking material is delivered to the patient.

Abstract: A wireless parking meter with an improved antenna location is described. The antenna may be located within a covering protruding from the top of the parking meter, allowing radio frequency (RF) signals to be transmitted through a portion of the parking meter with high permittivity to the RF signals. Additionally or alternatively, the antenna may be located within the parking meter housing above a lower parking meter mechanism housing so that RF signals can be transmitted through the dome covering of the parking meter, which may have a high permittivity to the RF signals.

Abstract: Methods that may be used for the manufacture of the chemical compound (R)-Reticuline and synthesis precursors thereof. Compositions useful for the synthesis (R)-Reticuline and synthesis precursors are also provided.

Abstract: In some example embodiments, an indication of a selected data point of a current visualization can be received. A context of the selected data point can be determined based on a dimension of the data point, and explanation candidates can be generated based on the context of the selected data point. Each exploration candidate can have a different dimension context that is within the context of the selected data point and a corresponding value for the dimension context. For each one of the explanation candidates, a corresponding score can be generated based on a difference between the value for the explanation candidate and an average value of all the values of the explanation candidates. The explanation candidates can be ranked based on the scores. At least one of the explanation candidates can be selected based on the ranking, and selectable explanation(s) for the selected explanation candidate(s) can be displayed.

Abstract: A wet wipe that exhibits a novel combination of properties and methods for making such wet wipes are provided.

Abstract: The present technology is directed generally to devices, systems, and methods for enclosing anatomical openings. In one example, an aneurysm device is endovascularly deliverable to a site proximate to an arterial aneurysm. The aneurysm device can include a closure structure having a distal-facing aspect configured to at least partially occlude the aneurysm and a proximal-facing aspect configured to arch over lumina of an artery. The closure structure can include a plurality of struts forming support arms and anchoring arms. The device further includes a supplemental stabilizer connected to the closure structure and configured to reside in the artery and press outward against a luminal wall thereof. A barrier can span at least a portion of the distal-facing aspect of the closure structure and be configured to further occlude a neck of the aneurysm. The closure structure can be configured to restrict and/or divert flow to or from the aneurysm.

Abstract: The present technology is directed generally to devices, systems, and methods for enclosing anatomical openings. In one example, an aneurysm device is endovascularly deliverable to a site proximate to an arterial aneurysm. The aneurysm device can include a closure structure having a distal-facing aspect configured to at least partially occlude the aneurysm and a proximal-facing aspect configured to arch over lumina of an artery. The closure structure can include a plurality of struts forming support arms and anchoring arms. The device further includes a supplemental stabilizer connected to the closure structure and configured to reside in the artery and press outward against a luminal wall thereof. A barrier can span at least a portion of the distal-facing aspect of the closure structure and be configured to further occlude a neck of the aneurysm. The closure structure can be configured to restrict and/or divert flow to or from the aneurysm.

Abstract: Embodiments herein are directed to methods of heterotrophically culturing a. Embodiments herein are directed to methods, systems, and bioreactors for heterotrophically culturing Euglena sp. microorganism, a Schizochytrium sp. microorganism, or a Chlorella sp. microorganism comprising: culturing the microorganism in a culture media containing one or more carbon source, one or more nitrogen source, and one or more salt; maintaining a pH of between about 2.0 to about 4.0; maintaining a temperature of about 20° C. to about 30° C.; and maintaining an environment with substantially no light; wherein the culturing occurs in three cultivation stages.

Abstract: A personal communication system generates a request for initial schedule information corresponding to an initial workforce schedule generated by an enterprise analysis system. The personal communication system transmits the request for initial schedule information to the enterprise analysis system and receives a response including the initial schedule information. The personal communication system then generates a view of the initial workforce schedule based on the initial schedule information and displays the view of the initial workforce schedule in a primary application running on the personal communication system. The personal communication system then monitors for schedule factors relevant to the initial workforce schedule and transmits the schedule factors for use by the enterprise analysis system in generating an updated workforce schedule.